Dr. Hönle AG

Dr. Hönle AG announces figures for the first quarter of financial year 2006/2007

@@start.t1@@--------------------------------------------------------------------------------   ots.CorporateNews transmitted by euro adhoc. The issuer is responsible for   the content of this announcement. --------------------------------------------------------------------------------@@end@@

Graefeling/Munich (euro adhoc) - The UV specialist Dr. Hönle AG (WKN 515710) published figures for the first quarter of financial year 2006/2007. According to these, the Hönle Group sales revenues with TE 5,598 were at the same level as in the previous year (PY: TE 5,569). At TE 633, the operative result (EBIT) was below the comparable previous year's value of TE 821. Earnings before taxes (EBT) amounted to TE 787 (PY: TE 968), and consolidated net income came to TE 469 (PY: TE 573). The EBIT margin was 11.3 % (PY: 14.7 %) in the first quarter of financial year 2006/2007, and net profit on sales was 8.4 % (PY: 10.3 %).

Sales revenues that were only slightly above those of the previous year are due to project-related quarterly fluctuations and the postponement of delivery dates to the following quarter. Incoming orders were very satisfactory: the number of orders on hand at the end of the quarter is significantly above the previous year's level.

As planned, Hönle extended its sales team strongly at the end of the past financial year with a view to implementing the growth aimed for. The Company assumes that this will contribute positively to earnings from the second half of the year onwards.

All Group companies achieved a positive or a balanced result in the first quarter. In this respect, Aladin GmbH, which succeeded in increasing its operating result by 42.7 % in the first quarter, deserves special mention. Hönle expects a positive course of business for all Group companies during the rest of the financial year - in particular at Aladin GmbH and the recently restructured Wellomer GmbH and Hönle Spain S.A..

Outlook: Hönle is in a stable market environment. This is also reflected in the amount of incoming orders which, at the end of the reporting period, is significantly above that of the previous year. Consequently, the Company is holding to its announced 10 % sales growth and 25% growth in the operative result (EBIT) for financial year 2006/2007.

@@start.t2@@end of announcement                                                 euro adhoc 14.02.2007 06:10:00
--------------------------------------------------------------------------------@@end@@

ots Originaltext: Dr. Hönle AG
Im Internet recherchierbar: http://www.presseportal.ch

Further inquiry note:

Branche: Instrument Engineering
ISIN:      DE0005157101
WKN:        515710
Index:    CDAX, Prime All Share, Technologie All Share
Börsen:  Frankfurter Wertpapierbörse / regulated dealing/prime
              standard
              Börse Berlin-Bremen / free trade
              Hamburger Wertpapierbörse / free trade
              Baden-Württembergische Wertpapierbörse / free trade
              Börse Düsseldorf / free trade
              Niedersächsische Börse zu Hannover / free trade
              Bayerische Börse / free trade



Weitere Meldungen: Dr. Hönle AG

Das könnte Sie auch interessieren: